San Diego, CA, United States of America

Hong Qi

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hong Qi

Introduction

Hong Qi is a notable inventor based in San Diego, CA. He holds a total of 4 patents that focus on advancements in the field of otic formulations. His work has contributed significantly to the treatment of various ear diseases and conditions.

Latest Patents

Among his latest patents are the triglyceride otic formulations and their uses. These formulations are designed to treat otic diseases and conditions effectively. The compositions are derived from long-chain triglycerides, allowing for the delivery of a variety of therapeutic agents to the outer, middle, and inner ear. Additionally, he has developed similar formulations based on medium-chain triglycerides, further enhancing the therapeutic options available for ear treatments.

Career Highlights

Throughout his career, Hong Qi has worked with prominent companies in the pharmaceutical industry. He has been associated with Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Hong Qi has collaborated with several professionals in his field, including Scott H. Coleman and Robert Savel. These collaborations have likely contributed to the innovative nature of his work and the successful development of his patents.

Conclusion

In summary, Hong Qi is an accomplished inventor whose work in triglyceride otic formulations has the potential to revolutionize the treatment of ear diseases. His contributions to the pharmaceutical industry are noteworthy and reflect his dedication to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…